Document Detail


The role of oral L-carnitine therapy in chronic hemodialysis patients.
MedLine Citation:
PMID:  20427868     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To evaluate the effects of L-carnitine oral supplementation on anemia and cardiac function in patients on maintenance hemodialysis (HD), we studied 55 adult chronic HD patients at our center during the period from January 2006 to June 2006 and divided them into two groups; a group of 20 patients who received 1500 mg/day oral L-carnitine and a control group of 35 patients. Both groups were on erythropoietin therapy. Echogardiographic studies were performed before and at the end of the study. The mean hemoglobin levels were comparable in the L-carnitine group and the control group at the start and after 6 months of therapy (8.63 +/- 1.77 and 9.39 +/- 2.02 gm/dL, P = 0.18; 10.49 +/- 1.65 and 10.92 +/- 2.48 gm/dL, P = 0.76, respectively). The mean weekly maintenance dose of erythropoietin was not statistically significantly different in L-carnitine group (80.16 +/- 35.61 units/kg) and the control group (91.9 +/- 38.21 units/kg, P = 0.20). In addition no significant improvement could be observed in the echogardiographic findings in the L-carnitine group after therapy. We conclude that our study revealed no significant improvement in hemoglobin, erythropoietin dose and echocardiographic findings after six months of therapy. Long-term studies including larger number of patients are required to clarify the questionable role of L-carnitine in the HD patients.
Authors:
Alaa A Sabry
Related Documents :
11309228 - Paradigm change in 30 years peritonitis treatment -- a review on source control.
1289278 - Candida peritonitis: successful treatment with capd in two patients.
17631678 - Learning curve of combined modality treatment in peritoneal surface disease.
15012688 - Low glucose degradation products dialysis solution modulates the levels of surrogate ma...
17697218 - A study of airway management using the proseal lma laryngeal mask airway compared with ...
21178598 - Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia     Volume:  21     ISSN:  1319-2442     ISO Abbreviation:  Saudi J Kidney Dis Transpl     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9436968     Medline TA:  Saudi J Kidney Dis Transpl     Country:  Saudi Arabia    
Other Details:
Languages:  eng     Pagination:  454-9     Citation Subset:  IM    
Affiliation:
Nephrology Department, Urology and Nephrology Center, Mansoura University, Egypt. asabry2040@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Anemia / blood,  drug therapy,  etiology
Carnitine / administration & dosage*
Chronic Disease
Dietary Supplements*
Echocardiography
Egypt
Erythropoietin / administration & dosage
Female
Hematinics / administration & dosage
Hemoglobins / metabolism
Humans
Kidney Diseases / blood,  complications,  drug therapy,  physiopathology,  therapy*
Male
Middle Aged
Renal Dialysis*
Time Factors
Treatment Outcome
Ventricular Function / drug effects
Young Adult
Chemical
Reg. No./Substance:
0/Hematinics; 0/Hemoglobins; 11096-26-7/Erythropoietin; 541-15-1/Carnitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors associated with decision-making about end-of-life care by hemodialysis patients.
Next Document:  Changes in QT intervals in patients with end-stage renal disease before and after hemodialysis.